Every year, thousands of babies are born with underdeveloped lungs due to harmful exposures during pregnancy—one of the most common being nicotine. This can lead to lifelong breathing problems and even affect future generations. But what if we could use the body’s own biology—and even stem cell–based strategies—to protect developing lungs?

This study explores how a traditional therapy, electroacupuncture (EA), may help counteract the damaging effects of nicotine exposure during pregnancy. The researchers focused on how EA influences the mother’s gut microbiome—the community of bacteria in the digestive system—and how this, in turn, affects the baby’s lung development.

The gut microbiome produces short-chain fatty acids (SCFAs), natural compounds that help regulate inflammation and tissue development. These SCFAs can influence how organs like the lungs grow and repair themselves—an area of great interest to stem cell researchers working to regenerate damaged tissues.

In this study, pregnant rats exposed to nicotine showed disrupted gut bacteria and lower SCFA levels. Their offspring had poor lung development and function. But when the mothers received EA treatment, their gut microbiomes improved, SCFA levels increased, and their babies’ lungs developed more normally.

To test whether the gut bacteria were truly responsible, the researchers used antibiotics to wipe out the microbiome. Without these bacteria, EA no longer helped the babies’ lungs—confirming the critical role of the gut-lung connection.

This study highlights how biological systems—like the gut microbiome—can be harnessed to support organ development and repair. It also opens the door to future therapies that combine stem cell–based approaches with microbiome modulation to treat or prevent lung diseases in newborns.

By connecting ancient practices like acupuncture with cutting-edge science in stem cells and regenerative medicine, this research offers new hope for protecting the most vulnerable lungs—before a baby even takes its first breath.